JACKSON – Mississippi will receive more than $236,000 as part of a multistate settlement with a generic drug manufacturer accused of conspiring to inflate prices and limit competition, Attorney General Lynn Fitch announced Wednesday.
Fitch joined a coalition of 48 states and territories in announcing the $29.6 million settlement with Glenmark. The company was accused of participating in a widespread, long-running conspiracy involving numerous generic prescription drugs.
Mississippi’s share of the settlement is $236,595.47.
“Generic drugs are supposed to be a more affordable alternative, and they are often a lifeline for Americans who rely on them,” Fitch said. “We are holding the companies that kept prices artificially high accountable for taking advantage of families, and I encourage any Mississippian who thinks they may be eligible to register today.”
The Glenmark agreement follows settlements with Lannett, Bausch, Apotex and Heritage totaling $66.95 million.
People who purchased generic prescription drugs manufactured by Glenmark, Lannett, Bausch, Apotex or Heritage between May 2009 and December 2019 may be eligible for compensation.
Consumers can determine their eligibility by calling 1-866-290-0182, emailing info@AGGenericDrugs.com or visiting AGGenericDrugs.com.
Mississippi is among 48 states and territories participating in the Glenmark settlement.